LONG-TERM OUTCOMES OF TACROLIMUS VS. ANTI-TUMOR NECROSIS FACTOR AGENTS IN THE TREATMENT FOR ULCERATIVE COLITIS: A MULTI-INSTITUTIONAL, PROPENSITY SCORE MATCHING COMPARATIVE EFFICACY STUDY

被引：0
|
作者：
Yamada, Takuya
Yoshihara, Takeo
Amano, Takahiro
Sakakibara, Yuko
Osugi, Naoto
Ishii, Shuji
Egawa, Satoshi
Araki, Manabu
Arimoto, Yuki
Nakahara, Masanori
Murayama, Yoko
Kobayashi, Ichizo
Kinoshita, Kazuo
Ogawa, Hiroyuki
Hiyama, Satoshi
Shibukawa, Narihiro
Komori, Masato
Okuda, Yorihide
Kizu, Takashi
Shinzaki, Shinichiro
Iijima, Hideki
Tsujii, Yoshiki
Hayashi, Yoshito
Takehara, Tetsuo
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
EP143
引用
收藏
页码：S1217 / S1217
页数：1
相关论文
共 25 条
  • [11] Long-Term Efficacy of Anti-Tumor Necrosis Factor Agents in Pediatric Luminal Crohn's Disease: A Systematic Review of Real-World Evidence Studies
    van Rheenen, Hanna
    van Rheenen, Patrick Ferry
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2020, 23 (02) : 121 - 131
  • [12] Long-term safety of in utero exposure to anti-tumor necrosis factor for the treatment of inflammatory bowel diseases: results from the multicenter European TEDDY study
    Chaparro, M.
    Verreth, A.
    Lobaton, T.
    Gravito-Soares, E.
    Julsgaard, M.
    Savarino, E.
    Magro, F.
    Biron, I. Avni
    Lopez-Serrano, P.
    Casanova, M.
    Gompertz, M.
    Vitor, S.
    Arroyo, M.
    Pugliese, D.
    Zabana, Y.
    Vicente, R.
    Aguas, M.
    Shitrit, A. Bar-Gil
    Gutierrez, A.
    Doherty, G.
    Fernandez-Salazar, L.
    Cadilla, J. Martinez
    Huguet, J.
    O'Toole, A.
    Stasi, E.
    Marcos, N. Mancenido
    Villoria, A.
    Karmiris, K.
    Rahier, J.
    Rodriguez, C.
    Palomares, M. Diz-Lois
    Fiorino, G.
    Benitez, J.
    Principi, M.
    Naftali, T.
    Taxonera, C.
    Mantzaris, G.
    Sebkova, L.
    Iade, B.
    Lissner, D.
    Bradley, I. Ferrer
    Roman, A. Lopez-San
    Marin-Jimenez, I.
    Merino, O.
    Sierra, M.
    Van Domselaar, M.
    Caprioli, F.
    Guerra, I.
    Peixe, P.
    Piqueras, M.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S34 - S35
  • [13] 1-Year Comparison of Clinical and Endoscopic Outcomes of Tofacitinib vs Vedolizumab for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure: A Real-World Cohort Study in the United States
    Dalal, Rahul S.
    Sharma, Puza P.
    Bains, Kanwal
    Pruce, Jordan C.
    Allegretti, Jessica R.
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (08) : 1419 - 1422
  • [14] Long-term outcomes of endoscopic balloon dilation for intestinal strictures in patients with Crohn's disease during maintenance treatment with anti-tumor necrosis factor alpha antibodies
    Takeda, Teruyuki
    Kishi, Masahiro
    Takatsu, Noritaka
    Takada, Yasumichi
    Beppu, Tsuyoshi
    Miyaoka, Masaki
    Hisabe, Takashi
    Ueki, Toshiharu
    Arima, Hisatomi
    Hirai, Fumihito
    Yao, Kenshi
    DIGESTIVE ENDOSCOPY, 2022, 34 (03) : 517 - 525
  • [15] Small-Bowel Crohn Disease Treated With Anti-Tumor Necrosis Factor-α Therapy: MR Enterography Score Changes After I Year Predict Long-Term Outcomes
    Gallegos, Jose C.
    de Joe, Carlos
    Echarri, Ana
    Lopez-de-Ullibarri, Ignacio
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 213 (06) : 1240 - 1246
  • [16] Early Ileocecal Resection for Crohn's Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study
    Agrawal, Manasi
    Ebert, Anthony C.
    Poulsen, Gry
    Ungaro, Ryan C.
    Faye, Adam S.
    Jess, Tine
    Colombel, Jean-Frederic
    Allin, Kristine H.
    GASTROENTEROLOGY, 2023, 165 (04) : 976 - 985.e3
  • [17] LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS WITH AND WITHOUT PRIOR ANTI-TUMOR NECROSIS FACTOR EXPOSURE: 96-WEEK OUTCOMES OF THE RAPID-PSA TRIAL
    Mease, P. J.
    Fleischmann, R.
    Wollenhaupt, J.
    Deodhar, A.
    Gladman, D.
    Arledge, T.
    Peterson, L.
    van der Heijde, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 786 - 786
  • [18] LONG-TERM EFFICACY AND SAFETY OF SIRUKUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE ANTI-TUMOR NECROSIS FACTOR THERAPY: RESULTS OF THE RANDOMIZED, PHASE 3 SIRROUND-T STUDY
    Tanaka, Y.
    Aletaha, D.
    Agarwal, P.
    Kurrasch, R.
    Tak, P. P.
    Popik, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 563 - 564
  • [19] ILEOCECAL RESECTION FOR RECENTLY DIAGNOSED ILEOCECAL CROHN'S DISEASE IS ASSOCIATED WITH IMPROVED LONG-TERM OUTCOMES COMPARED TO ANTI-TUMOR NECROSIS FACTOR THERAPY: A POPULATION-BASED STUDY
    Agrawal, Manasi
    Ebert, Anthony C.
    Poulsen, Gry
    Ungaro, Ryan C.
    Faye, Adam S.
    Jess, Tine
    Colombel, Jean Frederic
    Allin, Kristine H.
    GASTROENTEROLOGY, 2023, 164 (06) : S4 - S4
  • [20] LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS WITH AND WITHOUT PRIOR ANTI-TUMOR NECROSIS FACTOR EXPOSURE: 96-WEEK OUTCOMES FROM THE RAPID-PSA TRIAL
    Mease, P. J.
    Fleischmann, R.
    Wollenhaupt, J.
    Deodhar, A.
    Gladman, D.
    Hoepken, B.
    Peterson, L.
    van der Heijde, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 90 - 90
123